HER growth proteins do not predict outcome of herceptin treatment breast cancer patients
Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer – Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient’s outcome after treatment for HER2 Positive Breast Cancer with Herceptin, say Mayo Clinic researchers.